CS-944X

N/A

Report date: 2025/01/26 18:14:27
NME

Base Information

Drug NameCS-944X
Drug Alias NameCS-944X
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitorsTyrosine-protein kinase JAK3 inhibitors
TargetsTyrosine-protein kinase JAK3Tyrosine-protein kinase JAK1
Therapy Area/IndicationsPsoriasisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenzhen Chipscreen Biosciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Chipscreen Biosciences Co Ltd
Inactive CompaniesN/A
Active IndicationsPsoriasisArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A